1-4 of 4
mechlorethamine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Teclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma

Kodandaram Pillarisetti, Gordon Powers, Leopoldo Luistro, Alexander Babich, Eric Baldwin, Yingzhe Li, Xiaochun Zhang, Mark Mendonça, Nate Majewski, Rupesh Nanjunda, Diana Chin, Kathryn Packman, Yusri Elsayed, Ricardo Attar, François Gaudet
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4538–4549.
https://doi.org/10.1182/bloodadvances.2020002393
Published: 2020
Includes: Supplemental data
Journal Articles

Acute myeloid leukemia–induced T-cell suppression can be reversed by inhibition of the MAPK pathway

Kaycee B. Moshofsky, Hyun J. Cho, Guanming Wu, Kyle A. Romine, Matthew T. Newman, Yoko Kosaka, Shannon K. McWeeney, Evan F. Lind
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3038–3051.
https://doi.org/10.1182/bloodadvances.2019000574
Published: 2019
Journal Articles

A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant

Shauna L. French, Claudia Thalmann, Paul F. Bray, Lynn E. Macdonald, Andrew J. Murphy, Mark W. Sleeman, Justin R. Hamilton
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1283–1293.
https://doi.org/10.1182/bloodadvances.2017015552
Published: 2018
Includes: Supplemental data
Journal Articles

Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease

Clinical Trials & Observations
Joshua J. Field, Elaine Majerus, Victor R. Gordeuk, Michel Gowhari, Carolyn Hoppe, Matthew M. Heeney, Maureen Achebe, Alex George, Hillary Chu, Brian Sheehan, Maneka Puligandla, Donna Neuberg, Gene Lin, Joel Linden, David G. Nathan
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1645–1649.
https://doi.org/10.1182/bloodadvances.2017009613
Published: 2017
Includes: Supplemental data